NO20021993D0 - Redoksreversible HCV-proteiner med nativlignende konformasjon - Google Patents

Redoksreversible HCV-proteiner med nativlignende konformasjon

Info

Publication number
NO20021993D0
NO20021993D0 NO20021993A NO20021993A NO20021993D0 NO 20021993 D0 NO20021993 D0 NO 20021993D0 NO 20021993 A NO20021993 A NO 20021993A NO 20021993 A NO20021993 A NO 20021993A NO 20021993 D0 NO20021993 D0 NO 20021993D0
Authority
NO
Norway
Prior art keywords
conformation
native
hcv proteins
redox reversible
redox
Prior art date
Application number
NO20021993A
Other languages
English (en)
Other versions
NO20021993L (no
Inventor
Alfons Bosman
Erik Depla
Geert Maertens
Original Assignee
Innogenetics Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/EP2000/010499 external-priority patent/WO2001030815A1/en
Application filed by Innogenetics Nv filed Critical Innogenetics Nv
Publication of NO20021993D0 publication Critical patent/NO20021993D0/no
Publication of NO20021993L publication Critical patent/NO20021993L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C07K14/08—RNA viruses
    • C07K14/18—Togaviridae; Flaviviridae
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
    • C07K16/1081—Togaviridae, e.g. flavivirus, rubella virus, hog cholera virus
    • C07K16/109—Hepatitis C virus; Hepatitis G virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24211—Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
    • C12N2770/24222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Communicable Diseases (AREA)
  • Immunology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
NO20021993A 1999-10-27 2002-04-26 Redoks-reversible HCV-proteiner med en konformasjon som ligner den native NO20021993L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP99870225 1999-10-27
US16928899P 1999-12-07 1999-12-07
PCT/EP2000/010499 WO2001030815A1 (en) 1999-10-27 2000-10-25 Redox reversible hcv proteins with native-like conformation

Publications (2)

Publication Number Publication Date
NO20021993D0 true NO20021993D0 (no) 2002-04-26
NO20021993L NO20021993L (no) 2002-06-27

Family

ID=26153862

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20021993A NO20021993L (no) 1999-10-27 2002-04-26 Redoks-reversible HCV-proteiner med en konformasjon som ligner den native

Country Status (4)

Country Link
KR (1) KR20020047286A (no)
HK (1) HK1049847A1 (no)
IL (1) IL148931A0 (no)
NO (1) NO20021993L (no)

Also Published As

Publication number Publication date
KR20020047286A (ko) 2002-06-21
HK1049847A1 (zh) 2003-05-30
NO20021993L (no) 2002-06-27
IL148931A0 (en) 2002-09-12

Similar Documents

Publication Publication Date Title
DE60004785D1 (de) Reversibele unabhängige kocheinheit
DE60011853D1 (de) Injektionsspritze
IS2231B (is) Nýjar amínóprópýlfosfínsýrur
PT1060695E (pt) Cadeira empilhavel
DK1244641T3 (da) Thiazolylamid-derivater
NO20020526D0 (no) Moksifloksasinformulering med koksalt
ATE459356T1 (de) Indolyl-3-glyoxylsäure-derivate mit therapeutisch wertvollen eigenschaften
DE50005284D1 (de) Substituierte n-benzyl-indol-3-yl- glyoxylsäure-derivate mit antitumorwirkung
EE200100708A (et) Asendatud fenoksüäädikhapped
NO20032614D0 (no) Farmasöytisk sammensetning med forbedret absorbabilitet
NO20020155L (no) Aminotiazolderivater og deres anvendelse som CRF reseptorligander
ATE254598T1 (de) 4-hydroxybiphenylhydrazid-derivate
DE60003072D1 (de) Thiazolidindion-derivate als antidiabetika
DE60033909D1 (de) Interkalator mit Redox-Aktivität
HUP0203195A3 (en) Redox reversible hcv proteins with native-like conformation
TR200002831A3 (tr) Kinolin-4-Il türevleri I
FR2791348B1 (fr) POLYPEPTIDE Npt2B
NO20021993D0 (no) Redoksreversible HCV-proteiner med nativlignende konformasjon
DK1144660T3 (da) Glasnudler
DE10082298D2 (de) Chimäre Proteine
DE10084920T1 (de) Glaszusammensetzung
DE29900787U1 (de) Blendrahmen
DK1189600T3 (da) GRF-holdige lyofiliserede farmaceutiske præparater
DE60043224D1 (de) Krankheitsresistenz-faktoren
NO20021244L (no) Subenhet-optimaliserte fusjonsproteiner

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application